| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/21/2013 | CN103255113A Cyanea capillata peroxide reductase as well as encoding gene and application thereof |
| 08/21/2013 | CN103255110A Methods of improving the introduction of DNA into bacterial cells |
| 08/21/2013 | CN103254427A Acid-sensitive degradation-controllable serial polymers with branched structures and preparation method thereof |
| 08/21/2013 | CN103251960A DNA (deoxyribonucleic acid) vaccine for preventing chronic toxoplasmosis of humans or animals |
| 08/21/2013 | CN103251959A Novel use of fruit fly gene lk6 |
| 08/21/2013 | CN103251958A Applications of MEN1 gene and encoding protein thereof |
| 08/21/2013 | CN103251957A Treatment of spinal cord injury by transplanting stem cells modified by neurotrophic factor gene |
| 08/21/2013 | CN103251952A Genetic products differentially expressed in tumors and use thereof |
| 08/21/2013 | CN103251931A Application of Cyr61 in psoriasis medicine |
| 08/21/2013 | CN103251562A Method for improving stability and shelf-life of liposome complexes |
| 08/21/2013 | CN102864150B Nucleic acid aptamer capable of recognizing HCV NS5A protein, and derivatives, screening method and application thereof |
| 08/21/2013 | CN102755651B Anti-skin squamous cell carcinoma medicament antagomir-365-2 |
| 08/21/2013 | CN102397557B Modification method for gold nanorods and gold nanorods-functional molecule composite |
| 08/21/2013 | CN102114000B Co-feeding lipid nano-delivery system for medicine carrying |
| 08/21/2013 | CN102085378B Application of hfgl2 (Human Fibrinogen-like protein 2) inhibitor in preparation of medicaments for treating liver cancer |
| 08/21/2013 | CN102026647B Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 08/21/2013 | CN101935673B siRNA for inhibiting mouse gamma -GABA transfer protein subtype 1 |
| 08/21/2013 | CN101573382B Monoclonal antibodies and directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 08/20/2013 | US8513213 SDF-1 delivery for treating ischemic tissue |
| 08/20/2013 | US8513210 Prostate cancer vaccine |
| 08/20/2013 | US8513209 Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair |
| 08/20/2013 | US8513206 Crosslinked PEI nanoparticle transfection agents for delivery of biomolecules with increased efficiency |
| 08/20/2013 | US8513008 signaling cells with an interferon gamma receptor agonists and tumor necrosis factor agonists, then with a second signal comprising a CD40 agonist and natural killer cells, to produce chemokine receptor (CCR7) mature cells, used as immunostimulants |
| 08/20/2013 | US8513007 SDF-1 delivery for treating ischemic tissue |
| 08/20/2013 | US8512994 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 08/20/2013 | US8512993 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 08/20/2013 | US8512945 Method of RNA cleavage and recombination |
| 08/20/2013 | US8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 08/20/2013 | CA2641310C Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 08/20/2013 | CA2509520C Identification of oligonucleotides for the capture, detection and quantitation of west nile virus |
| 08/15/2013 | WO2013120092A1 Methods for predicting response to cancer therapy |
| 08/15/2013 | WO2013120038A2 Morpholino targeting dux4 for treating fshd |
| 08/15/2013 | WO2013119880A1 Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
| 08/15/2013 | WO2013119864A1 Increasing taxane sensitivity in cancer cells |
| 08/15/2013 | WO2013119705A2 Method of regulating cftr expression and processing |
| 08/15/2013 | WO2013118109A1 Methods and apparatuses harvesting, modifying and reimplantation of dermal micro -organs |
| 08/15/2013 | WO2013116965A1 Combined antigen and dna vaccine for preventing and treating rsv infection |
| 08/15/2013 | WO2013082515A3 Nucleic acid aptamers directed to surface receptors and methods of use |
| 08/15/2013 | US20130210899 Method and Therapeutic for the Treatment and Regulation of Memory Formation |
| 08/15/2013 | US20130210898 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same |
| 08/15/2013 | US20130210723 Use of the Insulin-Like-Growth Factor 1 Splice Variant MGF for the Prevention of Myocardial Damage |
| 08/15/2013 | US20130210717 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1 |
| 08/15/2013 | US20130210135 Recombinant vsv for the treatment of tumor cells |
| 08/15/2013 | US20130209546 Combinatorial methods and compositions for treatment of melanoma |
| 08/15/2013 | US20130209474 Wise/sost nucleic acid sequences and amino acid sequences |
| 08/15/2013 | US20130209451 Treatments for Cancer |
| 08/15/2013 | US20130209450 Compositions and Methods for Treating Glioblastoma GBM |
| 08/15/2013 | US20130209410 Expression vector for cholesterol 24 -hydrolase in therapy of huntington's disease |
| 08/15/2013 | US20130209409 Chimeric adenoviruses for use in cancer treatment |
| 08/14/2013 | EP2626427A2 Sirna conjugate and preparation method thereof |
| 08/14/2013 | EP2626418A1 Method for activating helper t cell |
| 08/14/2013 | EP2626130A1 Substance-encapsulating vesicle and process for producing the same |
| 08/14/2013 | EP2625274A2 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4 |
| 08/14/2013 | EP2625270A1 Glp-1 promoter mediated insulin expression for the treatment of diabetes |
| 08/14/2013 | EP2625195A2 Cancer targets |
| 08/14/2013 | CN103243151A Reagent for identifying glucocorticoid sensitivity of lymphocyte-derived tumor |
| 08/14/2013 | CN103243122A Nucleic acid substance carrier containing degradable imine linkage as well as preparation method and application thereof |
| 08/14/2013 | CN103243100A siRNA Molecule and anti-tumor application thereof |
| 08/14/2013 | CN103243098A RelA cut and TLR7 active sequence modified locked nucleic acid deoxyribozyme for targeted therapy of tuberculosis and application thereof |
| 08/14/2013 | CN103243091A MiRNA-140 inhibitor and applications thereof |
| 08/14/2013 | CN103243086A Method for modifying oligonucleotides, modified oligonucleotides obtained thereby and application of modified oligonucleotides |
| 08/14/2013 | CN103242523A Synthesis method of triblock copolymer PEI-PEG-PEI |
| 08/14/2013 | CN103242442A Method of applying lymphocytic leukemia molecular marker to preparing therapeutic agent |
| 08/14/2013 | CN103242428A Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same |
| 08/14/2013 | CN103242427A CTL epitope polypeptide of porcine reproductive and respiratory syndrome virus (PRRSV) and application thereof |
| 08/14/2013 | CN103242426A Avian influenza virus H5N1 subtype restrictive CTL epitope polypeptide and application thereof |
| 08/14/2013 | CN103242243A Base acetic acid glycerin ester ether molecule, chemical synthesis method of molecule, and application of molecule in field of gene therapy |
| 08/14/2013 | CN103239736A Method for adjusting glycolysis and gluconeogenesis and applications of method |
| 08/14/2013 | CN103239735A Regulating function of miR-29a (microRNA-29a) in mouse embryonic tumor cell |
| 08/14/2013 | CN103239734A Vaccine for prevention and/or treatment of respiratory syncytial virus infection |
| 08/14/2013 | CN103239728A Polycation surface-modified large-pore and mesoporous silicon nanoparticle, complex of nanoparticle and nucleic acid and application of nanoparticle |
| 08/14/2013 | CN103239716A Application of SIRT1 (silent information regulator 1) in preparation of medicines for treating severe burns or wounds |
| 08/14/2013 | CN103239714A Protein and pharmaceutical composition for treating ischemic diseases |
| 08/14/2013 | CN102614527B Antiacid nano oral deoxyribonucleic acid (DNA) anti-tumor vaccine with potential of hydrogen (pH) sensitive characteristic and preparation method |
| 08/14/2013 | CN102604128B Preparation method for gelatin nanosphere |
| 08/14/2013 | CN102423493B Medicine for eliminating breast cancer cells with high efficiency and high specificity |
| 08/14/2013 | CN102206676B Vector for controlling gender of animals and application thereof |
| 08/14/2013 | CN102198268B Recombinant Swine pox virus (SPV) vector vaccine for the expression of Streptococcus equi subsp zooepidemicus (SEZ) M-like protein (SzP) |
| 08/14/2013 | CN102174514B Double-stranded siRNA (Small Interfering Ribonucleic Acid) for suppressing Hmga2 gene expression and application thereof |
| 08/14/2013 | CN102166166B Method and application using compounds from fetal cells and tissues to improve skin condition |
| 08/14/2013 | CN102108356B Novel promoter and virus vector containing same |
| 08/14/2013 | CN101955543B Nerve growth factor bound with laminin, and coding gene and application thereof |
| 08/14/2013 | CN101942017B Tumor marker |
| 08/14/2013 | CN101711278B T4 bacteriophage bound to a substrate |
| 08/13/2013 | US8507663 Compositions and methods for inhibiting expression of CD274/PD-L1 gene |
| 08/13/2013 | US8507661 Modified iRNA agents |
| 08/13/2013 | US8507458 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron |
| 08/13/2013 | US8507455 Folate conjugates |
| 08/13/2013 | US8507277 Nonviral vectors for delivering polynucleotides |
| 08/13/2013 | US8507273 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 08/13/2013 | US8507267 AAV4 vector and uses thereof |
| 08/13/2013 | US8507211 Tuberculosis diagnostic test |
| 08/13/2013 | US8506948 UCB-MSCs comprising a tumor suppressor gene reduce the size of an IL-8 or GRO-αexpressing tumor |
| 08/13/2013 | US8506947 Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/13/2013 | CA2516777C Human cyclooxygenase-3 enzyme and uses thereof |
| 08/13/2013 | CA2464121C Pregnancy-associated plasma protein-a2 (papp-a2) |
| 08/13/2013 | CA2450020C Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using dna sequences |
| 08/13/2013 | CA2413995C Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity |
| 08/13/2013 | CA2330741C Methods of forming protein-linked lipidic microparticles, and compositions thereof |